Literature DB >> 1679294

Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.

W N Waugh1, L A Trissel, V J Stella.   

Abstract

The stability of taxol (NSC-125973) in various diluents and containers was determined, and the extent of leaching of di(2-ethylhexyl) phthalate (DEHP) from polyvinyl chloride (PVC) bags caused by the taxol formulation was measured. A taxol formulation consisting of a 6-mg/mL solution of taxol in 50% polyoxyethylated castor oil and 50% dehydrated ethanol was added to 50- and 100-mL glass bottles, PVC infusion bags, and polyolefin containers containing 5% dextrose injection or 0.9% sodium chloride injection to give initial nominal taxol concentrations of 0.3, 0.6, 0.9, and 1.2 mg/mL. The containers were maintained at 20-23 degrees C for 12-24 hours. Samples were assayed by stability-indicating high-performance liquid chromatography, and clarity was determined visually. An experiment was run to ascertain whether DEHP would leach from a PVC administration set during a simulated infusion. There was no substantial loss of taxol over 24 hours. Filtration through a membrane resulted in no loss of taxol. All the solutions initially appeared hazy. Solutions stored in PVC bags became more hazy with time than solutions stored in glass or polyolefin containers. The haze seen in PVC bags was traced to leaching of DEHP. Agitation had no effect on the extent of leaching. Leaching was also seen during simulated delivery through PVC administration sets. No DEHP was detected when solutions were stored in glass or polyolefin containers and infused through polyethylene-lined sets. At the dilutions studied, taxol was visually and chemically stable for up to 24 hours.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679294

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  16 in total

1.  Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.

Authors:  Deepti Pandita; Alka Ahuja; Viney Lather; Biju Benjamin; Tathagata Dutta; Thirumurthy Velpandian; Roop Krishen Khar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  New cytotoxic drugs and targets in oncology.

Authors:  J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

3.  Leachables from saline-containing IV bags can alter therapeutic protein properties.

Authors:  Judy Y Chang; Nina J Xiao; Min Zhu; Jennifer Zhang; Ed Hoff; Stephen J Russell; Viswanatham Katta; Steven J Shire
Journal:  Pharm Res       Date:  2010-06-30       Impact factor: 4.200

4.  Integrin-targeted paclitaxel nanoliposomes for tumor therapy.

Authors:  Shuyan Meng; Bo Su; Wei Li; Yongmei Ding; Liang Tang; Wei Zhou; Yin Song; Zhou Caicun
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

5.  Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum.

Authors:  Jae-Lyun Lee; Jin-Hee Ahn; Se Hoon Park; Ho Young Lim; Jung Hye Kwon; Shin Ahn; Cheryn Song; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  Invest New Drugs       Date:  2011-10-20       Impact factor: 3.850

6.  Development of novel chitosan derivatives as micellar carriers of taxol.

Authors:  A Miwa; A Ishibe; M Nakano; T Yamahira; S Itai; S Jinno; H Kawahara
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 7.  Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes.

Authors:  Liza C Villaruz; Mark A Socinski
Journal:  Eur J Cancer       Date:  2016-02-12       Impact factor: 9.162

8.  Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel.

Authors:  Adam W G Alani; Younsoo Bae; Deepa A Rao; Glen S Kwon
Journal:  Biomaterials       Date:  2009-12-03       Impact factor: 12.479

Review 9.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Evaluation of the effect of the concentration of plasticizer di(2-ethylhexyl) phthalate on the quantity of residual monomer vinyl chloride in PVC chest drainage tubes.

Authors:  Y I Kicheva; H Richter; E Popova
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.